Cognitive function in pituitary adenoma patients: A cross-sectional study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309586 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von David Krabbe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Cognition, Adenoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ALF-agreement, The Local Research and Development Council Gothenburg and Södra Bohuslän.
Abstract (Originalsprache)
Various factors may affect cognition in patients with pituitary adenoma, including size and extension of the tumor, degree of pituitary hormone deficiencies, and treatment of the tumor, most often being transsphenoidal surgery (TSS). The aim of this cross-sectional study was to evaluate cognitive function in patients with clinically significant pituitary adenoma and to identify factors influencing cognition. Sixty-eight patients with pituitary adenoma were included. Of these, 31 patients were evaluated before TSS and 37 patients 12 months following TSS. Cognitive function was evaluated by using the Repeatable Battery for the Assessment of Neuropsychological Status. Patients had lower mean scores on cognitive assessment compared to age-adjusted normative data. Variability in cognition, analyzed by linear regression analysis, was explained by sex, educational level, and self-perceived fatigue, but not by pituitary hormone deficiencies, diabetes insipidus, or surgical treatment. Our results are in line with previous findings, namely that pituitary adenoma affects cognition. To better evaluate the factors affecting cognition, longitudinal studies are recommended. Such studies would allow for within-individual comparisons, effectively controlling for the considerable influence of sex and education on test results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Late-Stage Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
- Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: David Krabbe, Katharina S Sunnerhagen, Daniel S Olsson, Gudmundur Johannsson
Förderung
- ALF-agreement
- The Local Research and Development Council Gothenburg and Södra Bohuslän
Zitieren
APA
Krabbe, D., Sunnerhagen, K. S., Olsson, D. S., Hallén, T., Ragnarsson, O., Skoglund, T., & Johannsson, G. (2024). Cognitive function in pituitary adenoma patients: A cross-sectional study. PLOS ONE. https://doi.org/10.1371/journal.pone.0309586
Vancouver
Krabbe D, Sunnerhagen KS, Olsson DS, Hallén T, Ragnarsson O, Skoglund T, et al. Cognitive function in pituitary adenoma patients: A cross-sectional study. PLOS ONE. 2024. doi:10.1371/journal.pone.0309586
BibTeX
@article{Krabbe2024,
author = {Krabbe, David and Sunnerhagen, Katharina S and Olsson, Daniel S and Hallén, Tobias and Ragnarsson, Oskar and Skoglund, Thomas and Johannsson, Gudmundur},
title = {Cognitive function in pituitary adenoma patients: A cross-sectional study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309586}
}
EUVIMED